4 Things to Know About BRCA Cancer Risk and Genetic Testing

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent. What does this mean for you? Read More

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent.What does this mean for you? Because there is no routine cancer, it is crucial to study an individual’s genetic makeup. Now, physicians and other healthcare providers can offer more high-quality, affordable options to study your genetics and assess cancer risk, including genetic tests for BRCA1 and BRCA2 gene mutations. Read More

4 Things to Know About BRCA Cancer Risk and Genetic Testing

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent. What does this mean for you? Read More

On June 13, 2013, the United States Supreme Court ruled that naturally occurring DNA cannot be subject to patent.What does this mean for you? Because there is no routine cancer, it is crucial to study an individual’s genetic makeup. Now, physicians and other healthcare providers can offer more high-quality, affordable options to study your genetics and assess cancer risk, including genetic tests for BRCA1 and BRCA2 gene mutations. Read More